Inventor
CHRISTENSEN SØREN
DK20 patents
⚠️ This page may combine multiple inventors who share the name “CHRISTENSEN SØREN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
H LUNDBECK AS
16 patentsUS10196439B2Feb 5, 2019
Antibodies specific for hyperphosphorylated tau and methods of use thereof
H LUNDBECK AS23 citations92
US11111290B2Sep 7, 2021
Antibodies specific for hyperphosphorylated tau and methods of use thereof
H LUNDBECK AS6 citations83
US10934348B2Mar 2, 2021
Antibodies specific for hyperphosphorylated tau and methods of use thereof
H LUNDBECK AS6 citations82
US10647762B2May 12, 2020
Antibodies specific for hyperphosphorylated tau and methods of use thereof
H LUNDBECK AS5 citations82
US10562962B2Feb 18, 2020
Antibodies specific for hyperphosphorylated tau and methods of use thereof
H LUNDBECK AS6 citations82
US10487142B2Nov 26, 2019
Antibodies specific for hyperphosphorylated tau and methods of use thereof
H LUNDBECK AS5 citations82
US10479835B2Nov 19, 2019
Agent, uses and methods for treatment
H LUNDBECK AS4 citations82
US10472415B2Nov 12, 2019
Antibodies specific for hyperphosphorylated tau and methods of use
H LUNDBECK AS5 citations82
US10428147B2Oct 1, 2019
Anti-sortilin antibodies, uses and methods for treatment
H LUNDBECK AS4 citations82
US10472414B2Nov 12, 2019
Antibodies specific to pyroglutamated Aβ
H LUNDBECK AS3 citations72
US11739140B2Aug 29, 2023
Antibodies specific for hyperphosphorylated tau and methods of use thereof
H LUNDBECK AS1 citations71
US11548950B2Jan 10, 2023
Agent, uses and methods for treatment
H LUNDBECK AS1 citations71
US10889650B2Jan 12, 2021
Agent, uses and methods for treatment
H LUNDBECK AS2 citations71
US10894833B2Jan 19, 2021
Agents, uses and methods for treatment
H LUNDBECK AS2 citations70
US12331123B2Jun 17, 2025
Agent, uses and methods for treatment
H LUNDBECK AS0 citations61
US12129289B2Oct 29, 2024
Antibodies specific for hyperphosphorylated tau and methods of use thereof
H LUNDBECK AS0 citations61